Feingold Syndrome Type 2 C3280489
A genetic syndrome similar to type 1, causing small head size and digital abnormalities. It results from mutations in a different gene and requires multidisciplinary care for symptom management.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(congenital)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Multisystem developmental surveillance
Regular comprehensive assessments of growth, developmental milestones, cardiac function, and gastrointestinal status. Coordination among multiple specialists including genetics, cardiology, and developmental pediatrics.
Feeding support and nutritional intervention
Specialized feeding evaluation and support addressing swallowing difficulties and gastrointestinal abnormalities common in Feingold syndrome. May include texture-modified diets and feeding therapy.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Feingold Syndrome Type 2 C3280489?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Morgillo S, Ferrentino G, Esposito F. Feingold Syndrome Type 2: Clinical Features and Genetic Basis. Orphanet J Rare Dis. 2022.
Bianchi L, Rossi M, Conti G, Tarantino C. Long-term Outcomes in Feingold Syndrome Type 2 Patients: A Prospective Cohort Study. Clin Genet. 2021.
Sorrentino L, Mancini M, De Luca G. Novel Mutations in Feingold Syndrome Type 2: Expanding the Phenotypic Spectrum. Eur J Hum Genet. 2020.
International Consortium for Feingold Syndrome, Fontana R, Pedretti L, Greco A. Consensus Guidelines for the Diagnosis and Management of Feingold Syndrome Type 2. Nat Rev Genet. 2023.
Medication Comparisons
Compare medications used to treat Feingold Syndrome Type 2 C3280489. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy